Abstract B026: Combined inhibition of mammalian target of rapamycin (mTOR) and survivin augments radiation therapy in renal cell carcinoma
Krishnendu Pal(Jacksonville College), Debabrata Mukhopadhyay(Jacksonville College), Vijay Sagar Madamsetty(Jacksonville College), Enfeng Wang(Jacksonville College), Shamit K. Dutta(WinnMed), Hari K. Rachamala(Jacksonville College)
Cited by 0
Related Papers
In vivo gene delivery mediated by non-viral vectors for cancer therapy
|Journal of Controlled Release|2020|240
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
|Frontiers in Pharmacology|2019|210
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
|ACS Biomaterials Science & Engineering|2022|174
Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C ζ
|Journal of Biological Chemistry|1998|164
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
|Advanced Functional Materials|2020|153